NEW YORK (TheStreet) -- CHANGE IN RATINGS:
Alon USA ALJ was downgraded at Goldman Sachs from buy to neutral. Valuation call, as the stock is up more than 33% since late December, Goldman said. $21 price target.
Associated Banc-Corp ASBC was downgraded at Oppenheimer to perform from outperform. Market has recognized turnaround, Oppenheimer said.
Associated Banc-Corp was upgraded at Morgan Stanley to equal-weight. $14 price target. Management is turning the business around, Morgan Stanley said.
AvalonBay Communities AVB was downgraded at Jefferies to hold from buy. $135 price target. 2013 outlook disappointment, Jefferies said.
Armstrong World AWI was upgraded at Barclays from equal-weight to overweight. $64 price target. Company will continue to benefit from a housing shortage, Barclays said.
Bed Bath & Beyond BBBY was upgraded at Citigroup to buy from neutral. $67 price target. Compelling valuation and improving differentiation, Citigroup said.
BB&T BBT was upgraded at Guggenheim from neutral to buy. $38 price target. Company will likely raise its dividend in the near term, Guggenheim said.
Baidu BIDU was downgraded at Stifel Nicolaus from buy to hold. Company is spending more to invest in online video and mobile internet, Stifel said.
Bank of NY Mellon BK was downgraded at Guggenheim from buy to neutral. Valuation call, based on a $28 price target, Guggenheim said.
Cullen/Frost Bankers CFR was upgraded at Oppenheimer to outperform from perform. $68 price target. Loan growth is beginning to accelerate, Oppenheimer said.
CIT Group CIT was downgraded at Nomura from buy to neutral. $45 price target. Valuation call, as the stock is up 16% over the past two months, Nomura said.
Clearwire CLWR was downgraded at DA Davidson from neutral to underperform. DISH deal will likely not go through, DA Davidson said. $2.97 price target.
DR Horton DHI was upgraded at Barclays from equal-weight to overweight. $27 price target. Expect better credit availability to drive demand for entry-level homes, Barclays said.
Bottomline EPAY was downgraded at Craig-Hallum from buy to hold. Valuation call, based on a $29 price target, Craig-Hallum said.
Equity Residential EQR was downgraded at Jefferies to hold from buy. $58 price target. Negative read-through from AVB results, Jefferies said.
Iconix Brand Group ICON was downgraded at Citigroup to neutral from buy. $25 price target. Buffalo acquisition nice, but pricey, Citigroup said.
Invesco BBT was downgraded at BMO Capital from outperform to market perform. Valuation call, based on a $29 price target, BMO said.
Kohl's KSS was downgraded at Citigroup to neutral from buy. $50 price target. Difficult turnaround attempt, Citi said.
Life Technologies LIFE was downgraded at Leerink Swann from outperform to market perform. Taking a cautious view on the next-generation sequencing business, and the stock has made a big run, Leerink Swann said.
Legg Mason LM was downgraded at BMO Capital from market perform to underperform. $26 price target. Company is not positioned well to participate in a reflection toward equities, BMO Capital said.
Macy's BBT was upgraded at Citigroup to buy from neutral. $46 price target. Benficiary of a stronger housing market, Citigroup said.
National Oilwell NOV was downgraded at Bernstein Research from outperform to market perform. $80 price target. Backlog will likely soon peak, Bernstein Research said.
National Oilwell Varco was downgraded at Bernstein to market perform from outperform. $80 price target. Expectations that backlogs will soon peak, Bernstein said.
New York Community Bancorp NYCB was upgraded at Morgan Stanley to overweight. $15 price target. Company restructured its debt, and net interest margin is holding up better than expected, Morgan Stanley said.
PulteGroup PHM was downgraded at Barclays from overweight to equal-weight. $21 price target. New-home prices will likely flatten out, Barclays said.
Realogy RLGY was downgraded at Barclays from overweight to equal-weight. Valuation call, based on a $46 price target, Barclays said.
Sandridge SD was downgraded at J.P. Morgan from overweight to underweight. $5 price target. Company faces a potential financial crunch, J.P. Morgan said.
State Street STT was downgraded at Guggenheim from buy to neutral. $63 price target. Valuation call, as the stock is up 32% since the fall, Guggenheim said.
Constellation Brands STZ was downgraded at Stifel Nicolaus from buy to hold. DOJ suit adds risk to the story.
Stillwater Mining SWC was upgraded at J.P. Morgan from neutral to overweight. $19 price target. Company is leveraged to rising palladium prices, J.P. Morgan said.
Stryker SYK was downgraded at UBS to neutral from buy. Reasonably valued and strong recent move, UBS said.
Target TGT was upgraded at Citigroup to buy from neutral. $72 price target. Well-positioned to gain market share through the new Threshold line, Citi said.
Toll Brothers TOL was downgraded at Barclays to underweight from equal-weight. $36 price target. Expect a shift toward more entry-level home buyers, Barclays said.
Ulta Salon ULTA was initiated with an outperform rating at Credit Suisse. $120 price target. Company has large competitive advantages and can continue to grow, Credit Suisse said.
UnitedHealth UNH was upgraded at Goldman Sachs from neutral to buy. Company was also placed on the Conviction List. Company is an industry leader and leveraged to health care reform, Goldman said. $68 price target.
Williams-Sonoma WSM was initiated with a neutral rating at Credit Suisse. $49 price target. Company has posted inconsistent results, Credit Suisse said.
Yum Brands YUM was downgraded at Robert Baird from outperform to neutral. $72 price target. China outlook remains uncertain and management lowered guidance, Baird said.
Zynga ZNGA was upgraded at Bank of America/Merrill Lynch from underperform to buy. Valuation call, based on a $3.40 price target, BofA/Merrill said.
Quiksilver ZQK was downgraded at B. Riley Caris from buy to neutral. $6.70 price target. Company remains exposed to Europe, B. Riley Caris said.
STOCK COMMENTS / EPS CHANGES
Abbott ABT target raised at Jefferies to $40, Jefferies said. Conservative guidance sets the stage for EPS momentum. Buy rating.
Edwards LifeSciences EW numbers raised at Jefferies. Shares of EW now seen reaching $114, Jefferies said. Estimates also raised on Sapian launch back on track. Buy rating.
Gilead Sciences GILD target lowered at OPPENHEIMER to $45, Oppenheimer said. Reflective of stock split. Outperform rating.
Humana HUM numbers raised at Jefferies. Shares of HUM now seen reaching $93, Jefferies said. Estimates also raised on rising confidence. Buy rating.
Marathon Petroleum MPC target raised at Oppenheimer to $90, Oppenheimer said. Strong outlook boosts valuation. Outperform rating.
Netflix NFLX estimates, target raised at BMO. Shares of NFLX now seen reaching $165, according to BMO Capital. Estimates also increased, given higher subscriber expectations. Market Perform rating.
Yum! Brands YUM numbers lowered at Oppenheimer. Shares of YUM now seen reaching $70. Estimates also lowered on China problems. Outperform rating.
>To submit a news tip, email: email@example.com.
READERS ALSO LIKE:
- Google vs. Apple: A Tale of Two Companies
- 5 Tax Tips You May Be Forgetting
- Jim Cramer: 10 Stock Picks for 2013 (Updated With Videos)